{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:21:33Z","timestamp":1791645693496,"version":"4.3.4"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Infection with the protozoan parasite <jats:italic>Toxoplasma gondii<\/jats:italic> occurs worldwide and usually causes no symptoms. However, a primary infection of pregnant women, may infect the fetus by transplacental transmission. The risk of mother-to-child transmission depends on week of pregnancy at the time of maternal infection: it is low in the first trimester, may reach 90% in the last days of pregnancy. Inversely, however, fetal disease is more severe when infection occurs early in pregnancy than later. Systematic serologic testing in pregnant women who have no antibodies at the beginning of pregnancy, can accurately reveal active maternal infection. Therefore, the risk of fetal infection should be assessed and preventive treatment with spiramycin must be introduced as soon as possible to reduce the risk of mother-to-child transmission, and the severity of fetal infection. When maternal infection is confirmed, prenatal diagnosis with Polymerase Chain Reaction (PCR) on amniotic fluid is recommended. If fetal infection is certain, the maternal treatment is changed to a combination of pyrimethamine-sulfonamide and folinic acid. Congenitally infected newborns are usually asymptomatic at birth, but at risk for tardive sequelae, such as blindness. When congenital infection is evident, disease include retinochoroiditis, cerebral calcifications, hydrocephalus, neurocognitive impairment. The diagnosis of congenital infection must be confirmed at birth and management, specific therapy, and follow-up with multidisciplinary counseling, must be guaranteed.<\/jats:p>","DOI":"10.3389\/fped.2022.894573","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:56:14Z","timestamp":1657126574000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":161,"title":["Congenital Toxoplasmosis: The State of the Art"],"prefix":"10.3389","volume":"10","author":[{"given":"Lina","family":"Bollani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Auriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Achille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Garofoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Umberto","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryssoula","family":"Tzialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.micinf.2006.03.023","article-title":"Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America).","volume":"8","author":"Peyron","year":"2006","journal-title":"Microbes Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/cid\/cis258","article-title":"Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009).","volume":"54","author":"McLeod","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ijpara.2011.01.005","article-title":"Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America.","volume":"41","author":"Khan","year":"2011","journal-title":"Int J Parasitol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182013001844","article-title":"Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping.","volume":"141","author":"Shwab","year":"2014","journal-title":"Parasitology."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens7010025","article-title":"Congenital toxoplasmosis: a plea for a neglected disease.","volume":"7","author":"Wallon","year":"2018","journal-title":"Pathogens."},{"key":"B6","first-page":"949","article-title":"Toxoplasmosis.","author":"Peyron","year":"2016","journal-title":"Infectious Diseases of the Fetus and Newborn Infant."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007807","article-title":"Acute Toxoplasma infection in pregnant women worldwide: a systematic review and meta-analysis.","volume":"13","author":"Rostami","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005222","article-title":"Congenital toxoplasmosis in France and the United States: one parasite, two diverging approaches.","volume":"11","author":"Peyron","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B9","first-page":"898","article-title":"Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots.","volume":"36","author":"Molan","year":"2019","journal-title":"Trop Biomed."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69078-9","article-title":"Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis.","volume":"10","author":"Bigna","year":"2020","journal-title":"Sci Rep."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","article-title":"Mother-to- child transmission of toxoplasmosis: risk estimates for clinical counselling.","volume":"353","author":"Dunn","year":"1999","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/INF.0b013e3181c80493","article-title":"In utero and at birth diagnosis of congenital toxoplasmosis: use of likelihood ratios for clinical management.","volume":"29","author":"Rabilloud","year":"2010","journal-title":"Pediatr Infect Dis J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1093\/cid\/ciu724","article-title":"The Austrian toxoplasmosis register, 1992-2008.","volume":"60","author":"Prusa","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3860","article-title":"Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States.","volume":"139","author":"Maldonado","year":"2017","journal-title":"Pediatrics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2471\/BLT.12.111732","article-title":"The global burden of congenital toxoplasmosis: a systematic review.","volume":"91","author":"Torgerson","year":"2013","journal-title":"Bull World Health Organ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/cid\/civ1035","article-title":"Effect of antenatal treatment on the severity of congenital toxoplasmosis.","volume":"62","author":"Wallon","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8010024","article-title":"Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group.","volume":"8","author":"Peyron","year":"2019","journal-title":"Pathogens."},{"key":"B18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis.","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-021-00610-y","article-title":"Infections at the maternal-fetal interface: an overview of pathogenesis and defence.","volume":"20","author":"Megli","year":"2022","journal-title":"Nat Rev Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.chom.2017.04.007","article-title":"Microbial vertical transmission during human pregnancy.","volume":"21","author":"Arora","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clp.2021.05.004","article-title":"The term newborn congenital infection.","volume":"48","author":"Moodley","year":"2021","journal-title":"Clin Perinatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.parint.2018.07.004","article-title":"Congenital toxoplasmosis: an overview of the neurological and ocular manifestations.","volume":"67","author":"Khan","year":"2018","journal-title":"Parasitol Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/INF.0b013e3182343096","article-title":"Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.","volume":"30","author":"Olariu","year":"2011","journal-title":"Pediatr Infect Dis J."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000277","article-title":"Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe.","volume":"2","author":"Gilbert","year":"2008","journal-title":"PLoS Negl Trop Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1086\/501360","article-title":"Outcome of treatment for congenital toxoplasmosis, 1981-2004: the national collaborative Chicago-based, congenital toxoplasmosis study.","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0140-6736(07)60072-5","article-title":"Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients\u2019 data.","volume":"369","author":"Thi\u00e9baut","year":"2007","journal-title":"Lancet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/cid\/cit032","article-title":"Congenital Toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.","volume":"56","author":"Wallon","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"crossref","first-page":"552.e1","DOI":"10.1016\/j.ajog.2010.06.002","article-title":"Long-term outcome of children with congenital toxoplasmosis.","volume":"203","author":"Berrebi","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"B29","first-page":"104","article-title":"Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.","volume":"64","author":"Faucher","year":"2012","journal-title":"J Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/INF.0000000000002598","article-title":"Characterization of congenital toxoplasmosis in Israel: a 17-year nationwide study experience.","volume":"39","author":"Kahan","year":"2020","journal-title":"Pediatr Infect Dis J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/cid\/cis264","article-title":"High burden of congenital toxoplasmosis in the United States: the strain hypothesis?","volume":"54","author":"Ajzenberg","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1017\/S0031182011001478","article-title":"Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis.","volume":"138","author":"Lindsay","year":"2011","journal-title":"Parasitology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/infdis\/jiu189","article-title":"Immune profiling of pregnant Toxoplasma infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokines.","volume":"210","author":"Pernas","year":"2014","journal-title":"J Infect Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.meegid.2004.12.004","article-title":"Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP.","volume":"6","author":"Ferreira","year":"2006","journal-title":"Infect Genet Evol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.ophtha.2021.03.009","article-title":"Ocular findings in infants with congenital toxoplasmosis after a toxoplasmosis outbreak.","volume":"128","author":"Concei\u00e7\u00e3o","year":"2021","journal-title":"Ophthalmology."},{"key":"B36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/eye.2009.140","article-title":"Ocular manifestations of congenital toxoplasmosis.","volume":"24","author":"Melamed","year":"2010","journal-title":"Eye."},{"key":"B37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10792-019-01242-1","article-title":"Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.","volume":"40","author":"Vishnevskia-Dai","year":"2020","journal-title":"Int Ophthalmol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1215","DOI":"10.1542\/peds.2007-2169","article-title":"Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study.","volume":"121","author":"Freeman","year":"2008","journal-title":"Pediatrics."},{"key":"B39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/INF.0000000000001614","article-title":"Ocular lesions in congenital toxoplasmosis in Santa Isabel do Iva\u00ed, Paran\u00e1, Brazil.","volume":"36","author":"Sanders","year":"2017","journal-title":"Pediatr Infect Dis J."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-04769-4","article-title":"Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned.","volume":"14","author":"Dubey","year":"2021","journal-title":"Parasit Vectors."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1086\/656397","article-title":"Identification of an atypical strain of Toxoplasma gondii as the cause of a waterborne outbreak of toxoplasmosis in Santa Isabel do Ivai, Brazil.","volume":"202","author":"Vaudaux","year":"2010","journal-title":"J Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.ophtha.2009.04.042","article-title":"Congenital toxoplasmosis in south eastern Brazil: results of early ophthalmologic examination of a large cohort of neonates.","volume":"116","author":"Vasconcelos-Santos","year":"2009","journal-title":"Ophthalmology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e687","DOI":"10.1016\/j.jogc.2018.05.036","article-title":"Toxoplasmosis in pregnancy: prevention, screening, and treatment.","volume":"40","author":"Paquet","year":"2018","journal-title":"J Obstet Gynaecol Can."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221709","article-title":"The cost effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.","volume":"14","author":"Binquet","year":"2019","journal-title":"PLoS One."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101814","article-title":"Toxoplasmosis screening during pregnancy in France: opinion of an expert panel for the CNGOF.","volume":"49","author":"Picone","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod."},{"key":"B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/s0950268803001948","article-title":"Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies.","volume":"132","author":"Gras","year":"2004","journal-title":"Epidemiol Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/archdischild-2018-316603","article-title":"Fifteen-minute consultation: management of the infant born to a mother with toxoplasmosis in pregnancy.","volume":"105","author":"Saso","year":"2020","journal-title":"Arch Dis Child Educ Pract Ed."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.cmi.2020.04.014","article-title":"Toxoplasma gondii-specific IgG avidity testing in pregnant women.","volume":"26","author":"Garnaud","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s15010-017-1111-3","article-title":"Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection.","volume":"46","author":"Rostami","year":"2018","journal-title":"Infection."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00505-20","article-title":"Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy.","volume":"58","author":"Teimouri","year":"2020","journal-title":"Clin Microbiol."},{"key":"B51","doi-asserted-by":"crossref","first-page":"761.e9","DOI":"10.1016\/j.cmi.2018.09.024","article-title":"Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study.","volume":"25","author":"Tomasoni","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"B52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/AOG.0b013e3181d57b09","article-title":"Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid.","volume":"115","author":"Wallon","year":"2010","journal-title":"Obstet Gynecol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1080\/14787210.2021.1941867","article-title":"Molecular diagnosis of toxoplasmosis: recent advances and a look to the future.","volume":"19","author":"Robert","year":"2021","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jama.2018.9396","article-title":"Effect of cell-free DNA screening vs direct invasive diagnosis on miscarriage rates in women with pregnancies at high risk of Trisomy 21: a randomized clinical trial.","volume":"320","author":"Malan","year":"2018","journal-title":"JAMA."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001684","article-title":"Treatments for toxoplasmosis in pregnancy.","volume":"1999","author":"Peyron","year":"1999","journal-title":"Cochr Database Syst Rev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1111\/j.1651-2227.2005.tb01844.x","article-title":"Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers.","volume":"94","author":"Gras","year":"2005","journal-title":"Acta Paediatr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/cid\/cis234","article-title":"Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy.","volume":"54","author":"Hotop","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/cid\/cit032","article-title":"Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.","volume":"56","author":"Wallon","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2019013","article-title":"Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy.","volume":"26","author":"Olariu","year":"2019","journal-title":"Parasite."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e00057","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice.","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin Microbiol Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"386.e1","DOI":"10.1016\/j.ajog.2018.05.031","article-title":"Prenatal therapy with pyrimethamine + sulfadiazine versus spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.","volume":"4","author":"Mandelbrot","year":"2018","journal-title":"Am J Obstet Gynecol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1097\/INF.0000000000003469","article-title":"Spyramicine and trimethoprim-sulfamethoxazole combination to prevent mother-to-fetus transmission of Toxoplasma gondii infection in pregnant women: a 28-years single-center experience.","volume":"41","author":"Buonsenso","year":"2022","journal-title":"Pediatr Infect Dis J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000445113","article-title":"Prognosis of fetal parenchymal cerebral lesions without ventriculomegaly in congenital toxoplasmosis infection.","volume":"41","author":"Dhombres","year":"2017","journal-title":"Fetal Diagn Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jogoh.2017.12.003","article-title":"An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection.","volume":"47","author":"Fallahi","year":"2018","journal-title":"Gynecol Obstet Hum Reprod."},{"key":"B65","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/BF01701522","article-title":"Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European research network on congenital toxoplasmosis.","volume":"15","author":"Lebech","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1128\/CVI.00060-12","article-title":"Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis.","volume":"19","author":"L\u2019Ollivier","year":"2012","journal-title":"Clin Vaccine Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1128\/JCM.00487","article-title":"Laboratory diagnosis of congenital toxoplasmosis.","volume":"54","author":"Pomares","year":"2016","journal-title":"J Clin Microbiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/INF.0b013e3181586052","article-title":"Early and accurate diagnosis of congenital toxoplasmosis.","volume":"27","author":"Ciardelli","year":"2008","journal-title":"Pediatr Infect Dis J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/aps.2011.55","article-title":"Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study.","volume":"32","author":"di Carlo","year":"2011","journal-title":"Acta Pharmacol Sin."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000351","article-title":"Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study.","volume":"7","author":"Cortina-Borja","year":"2010","journal-title":"PLoS Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1590\/s0074-02762009000200029","article-title":"Why prevent, diagnose and treat congenital toxoplasmosis?","volume":"104","author":"McLeod","year":"2009","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status.","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3238\/arztebl.2019.0435","article-title":"Toxoplasmosis in Germany.","volume":"116","author":"Pleyer","year":"2019","journal-title":"Dtsch Arztebl Int."},{"key":"B74","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review.","volume":"17","author":"Ben-Harari","year":"2017","journal-title":"Drugs R D."},{"key":"B75","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/INF.0000000000001120","article-title":"Treatment of congenital toxoplasmosis: safety of the sulfadoxine-pyrimethamine combination in children based on a method of causality assessment.","volume":"35","author":"Teil","year":"2016","journal-title":"Pediatr Infect Dis J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/INF.0b013e318134286d","article-title":"Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.","volume":"27","author":"Kieffer","year":"2008","journal-title":"Pediatr Infect Dis J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ajo.2007.07.013","article-title":"Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis.","volume":"144","author":"Tan","year":"2007","journal-title":"Am J Ophthalmol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/09273948.2013.779724","article-title":"Therapy for ocular toxoplasmosis\u2013the future.","volume":"21","author":"Garweg","year":"2013","journal-title":"Ocul Immunol Inflamm."},{"key":"B79","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.actatropica.2018.04.026","article-title":"Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.","volume":"185","author":"Zhang","year":"2018","journal-title":"Acta Trop."},{"key":"B80","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/09273948.2014.964422","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis: 10 years of follow-up.","volume":"23","author":"Silveira","year":"2015","journal-title":"Ocul Immunol Inflamm."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1542\/peds.113.6.1567","article-title":"Long-term ocular prognosis in 327 children with congenital toxoplasmosis.","volume":"113","author":"Wallon","year":"2004","journal-title":"Pediatrics."},{"key":"B82","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/INF.0b013e31820bb5f3","article-title":"Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance.","volume":"30","author":"Peyron","year":"2011","journal-title":"Pediatr Infect Dis J."},{"key":"B83","first-page":"11","article-title":"Neurologic and developmental outcome in treated congenital toxoplasmosis.","volume":"95","author":"Roizen","year":"1995","journal-title":"Pediatrics."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1086\/501360","article-title":"Outcome of treatment for congenital toxoplasmosis, 1981-2004: The national collaborative Chicago-based, congenital toxoplasmosis study.","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijporl.2009.01.012","article-title":"A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss.","volume":"73","author":"Brown","year":"2009","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/14992020903214053","article-title":"Maternal infection with Toxoplasma gondii in pregnancy and the risk of hearing loss in the offspring.","volume":"49","author":"Austeng","year":"2010","journal-title":"Int J Audiol."},{"key":"B87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15448\/1980-6108.2010.1.5927","article-title":"Congenital toxoplasmosis: auditory and language outcomes in early diagnosed and treated children.","volume":"20","author":"Resende","year":"2010","journal-title":"Sci Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s004310100805","article-title":"Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children.","volume":"160","author":"Wallon","year":"2001","journal-title":"Eur J Pediatr."},{"key":"B89","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1471-0528.2004.00302.x","article-title":"Reactivation of ocular toxoplasmosis during pregnancy.","volume":"112","author":"Garweg","year":"2005","journal-title":"BJOG."},{"key":"B90","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/20477724.2017.1370528","article-title":"Prophylaxis of human toxoplasmosis: a systematic review.","volume":"111","author":"Rajapakse","year":"2017","journal-title":"Pathog Glob Health."},{"key":"B91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejogrb.2007.09.010","article-title":"Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy.","volume":"136","author":"Gollub","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006171.pub4","article-title":"Prenatal education for congenital toxoplasmosis.","volume":"10","author":"Di Mario","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102300","article-title":"Hygiene measures as primary prevention of toxoplasmosis during pregnancy: a systematic review.","volume":"51","author":"Wehbe","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.fawpar.2019.e00036","article-title":"Treatment of toxoplasmosis: current options and future perspectives.","volume":"15","author":"Konstantinovic","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e01640","DOI":"10.1128\/AAC.01640-17","article-title":"Discovery of new inhibitors of Toxoplasma gondii via the pathogen box.","volume":"62","author":"Spalenka","year":"2018","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.894573\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:56:25Z","timestamp":1657126585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.894573\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":95,"alternative-id":["10.3389\/fped.2022.894573"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.894573","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"894573"}}